Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-30 Åä 00:03
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 148°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ® °¨¿°Ä¡·á ¾÷µ¥ÀÌÆ®
ÀÓ¼¼Çü ±âÀÚ
2019-01-11 15:10
[Interview]
±¹»ê P-CAB µîÀå, GERD Ä¡·á Áö°¢º¯µ¿ ¿¹°í
ÀÌ»óµ· ±âÀÚ
2019-01-11 15:05
[Sub Story]
°æÁõÀº ¼³ÆĻ츮Áø, ÁßÁõÀº ½ºÅ×·ÎÀ̵å·Î ÃÊÄ¡·á
ÀÓ¼¼Çü ±âÀÚ
2019-01-11 14:11
[Sub Story]
°¡¸é¡¤¹éÀÇ°íÇ÷¾Ð: °¡Á¤Ç÷¾Ð°ú 24½Ã°£È°µ¿Ç÷¾ÐÀÇ ÀÓ»óÀû È¿¿ë¼º
THE MOST
2018-11-08 15:52
[Conference Report]
±âÀü ´Ù¸¥ °·Â¡¤Áö¼Ó Ç÷¾Ð°ÇÏÁ¦ Çϳª·Î ¹¶Ä¡¸é
ÀÌ»óµ· ±âÀÚ
2018-11-08 13:24
¶óÀÎ
[Conference Report]
ÇǸ¶»ìźÀÇ ¶Ù¾î³ Ç÷¾Ð°ÇÏ È¿°ú, ISH 2018¿¡¼ ºÎ°¢
ÀÓ¼¼Çü ±âÀÚ
2018-11-08 11:49
[Cover Story]
º¸¿ÏµÈ ¸ÂÃãÄ¡·á·Î ¾Ï¿¹¹æºÎÅÍ »îÀÇ Áú °³¼±±îÁö
ÀÓ¼¼Çü ±âÀÚ
2018-07-16 16:59
[Sub Story]
Ç×»ýÁ¦ »ç¿ë°æÇè¿¡ µû¶ó Ä¡·áÀü·« °áÁ¤
ÀÓ¼¼Çü ±âÀÚ
2018-07-16 15:50
[Sub Story]
PPI Á᫐ °ü¸®Àü·« °Á¶
ÀÓ¼¼Çü ±âÀÚ
2018-07-16 15:34
[Sub Story]
PPI, Àå±â°£ »ç¿ë½Ã ¾ÈÀü¼º °í·Á ÇÊ¿äÇÏ´Ù
ÀÓ¼¼Çü ±âÀÚ
2018-07-16 15:19
¶óÀÎ
[Sub Story]
NICE 2014³â °¡À̵å¶óÀÎ, ¼ÒȺҷ®Áõ¡¤GERD ¡¤¼Òȼº ±Ë¾ç Ä¡·áÀü·« Á¦½Ã
ÀÌ»óµ· ±âÀÚ
2018-07-16 15:10
[Sub Story]
³Ä¡¼º GERD, ´ëüÀü·« ã±â¿¡ ºÐÁÖ
ÀÌ»óµ· ±âÀÚ
2018-07-16 15:04
[Sub Story]
¸ðƼ¸®Åæ, PPI ´ëºñ ºñ¿µîÇÑ È¿°ú
ÀÌ»óµ· ±âÀÚ
2018-07-16 14:59
[Drug Review]
¸ðƼ¸®Åæ, ±â´É¼º º¯ºñ¿¡µµ À¯È¿ÇÑ È¿°ú Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2018-07-16 14:55
[Sub Story]
±âħ Áö¼Ó±â°£¡¤Áõ»óÀ¸·Î ÀûÀýÇÑ Áø´Ü Àü·« Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2018-07-03 15:06
¶óÀÎ
[Sub Story]
Ç×Ç÷ÀüÄ¡·á: DAPTºÎÅÍ NOAC±îÁö
THE MOST
2018-06-07 18:45
[Sub Story]
°ñÀý Àç¹ß¿¹¹æ¿¡ ¾à¹°¿ä¹ý °Á¶
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:15
[Sub Story]
°ÇÃÊ¿° Áö¼Ó½Ã ·ù¸¶Æ¼½ºÀü¹®ÀÇ¿¡°Ô
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 15:49
[Sub Story]
ÅëÇÕÀû Æò°¡¸¦ ÅëÇÑ Ä¡·áÀü·« ±¸¼º
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 15:34
[Sub Story]
°í³óµµ ºñŸ¹ÎD ´Üµ¶¿ä¹ýÀÇ ÀÓ»ó¿ªÇÒ
ÀÓ¼¼Çü ±âÀÚ
2017-10-31 14:45
-
1
2
3
4
5
6
7
8
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top